Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached the details of the proposed schedule of Analyst/ Institutional Investor meeting.
The above information is a part of company’s filings submitted to BSE.